SYK · 10-Q · 2026Q3 · Full report

Revenue Performance and Mix

STRYKER CORP · 2026-10-30 · Importance 49 · Surprise 32

Third-quarter 2026 net sales increased 7.7% to $6,520 million, with constant-currency growth of 7.6% driven by unit volume and 0.1% by higher prices.,Nine-month 2026 net sales increased 6.6% to $19,129 million; constant-currency growth was 5.9%, and organic constant-currency growth was 6.2% after excluding a 0.5% acquisition and divestiture impact.,MedSurg and Neurotechnology sales grew 9.2% in the quarter and 8.0% for nine months, while Orthopaedics sales grew 5.7% and 4.9%, respectively.,For the nine months, U.S. sales increased 6.0% to $14,385 million and international sales increased 8.3% to $4,744 million.

Key facts

• In the three months of 2026, reported and organic net sales increased 7.7%, primarily driven by increased unit volume. source
• In the nine months of 2026, reported sales growth was 6.6% and organic net sales growth was 6.4%, primarily driven by increased unit volume. source
• Consolidated net sales in the three months increased 7.7% on both a reported and constant-currency basis; constant-currency sales grew 7.6% from unit volume and 0.1% from higher prices. source
• In the nine months, consolidated net sales increased 6.6% as reported and 5.9% in constant currency; foreign exchange positively affected sales by 0.7%. source
• In the nine months, excluding a (0.5)% impact from acquisitions and divestitures, constant-currency sales increased 6.2% from unit volume and 0.2% from higher prices. source
• MedSurg and Neurotechnology net sales in the three months increased 9.2% on reported and constant-currency bases; excluding a 0.1% acquisition and divestiture impact, constant-currency sales grew 8.9% from volume and 0.2% from higher prices. source
• MedSurg and Neurotechnology net sales in the nine months increased 8.0% as reported and 7.4% in constant currency; foreign exchange positively affected sales by 0.6%. source
• In the nine months, excluding a 0.8% acquisition and divestiture impact, MedSurg and Neurotechnology constant-currency sales increased 6.3% from volume and 0.3% from higher prices. source